OAR 332-026-0010: Approved Legend Drugs For Maternal Use

An LDM may administer the following legend drugs as approved by the Board for maternal use: (1) Anti-Hemorrhagics for use by intramuscular injection includes: (a) Synthetic Oxytocin (Pitocin, Syntocin and generic); (b) Methylergonovine (Methergine); or (c) Ergonovine (Ergotrate); (2) Anti-Hemorrhagics by intravenous infusion is limited to: (a) Synthetic Oxytocin (Pitocin, Syntocin, and generic); or (b) Tranexamic acid. (3) Anti-Hemorrhagics for oral administration is limited to: (a) Methylergonovine (Methergine); (b) Misoprostol (Cytotec). (4) Anti-Hemorrhagics for rectal administration is limited to Misoprostol (Cytotec). (5) Resuscitation is limited to medical oxygen and intravenous fluid replacement. (6) Intravenous fluid replacement includes: (a) Lactated Ringers Solution; (b) 0.9% Saline Solution; (c) D5LR (5% Dextrose in Lactated Ringers); or (d) D5W (5% Dextrose in water). (7) Anaphylactic treatment by subcutaneous injection is limited to Epinephrine. (8) Local anesthetic includes: (a) Lidocaine HCl (1% and 2%) (Xylocaine and generic); (b) Topical anesthetic; (c) Procaine HCl (Novocain, benzocaine, cetacane and generic); and (d) Sterile water papules. (9) Rhesus Sensitivity Prophylaxis is limited to Rho(d) Immune Globulin (RhoGAM, Gamulin Rh, Bay Rho-D and others). (10) Tissue adhesive (Dermabond or generic). (11) Intravenous antibiotics for Group B Streptococcal prophylaxis is limited to the following and is only to be used solely for the purpose of Group B Streptococcal prophylaxis: (a) Penicillin; (b) Ampicillin; (c) Cefazolin; or (d) Clindamycin.